Sarah Speight

Articles by Sarah Speight

Europe

In-house with Bayer: ‘Focus on quality early and stay close to inventors’

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking to Sarah Speight, the pair explain what makes a good IP strategy, why the UPC is largely “useless” without SPCs, and more.   15 July 2025

Careers

Kilpatrick adds ‘seasoned litigator’ as trademark partner

The new partner brings more than 30 years’ experience, including in counselling pharmaceutical, life sciences, and medical device companies.   10 July 2025

Europe

Lord Justice Birss to become chancellor of the High Court

The prominent senior IP judge is known for his groundbreaking judgments on patents, AI and FRAND, such as Unwired Planet, Thaler's DABUS, and InterDigital.   2 July 2025

Americas

A step too far? Why Stewart’s approach is dividing opinion

Coke Morgan Stewart has issued a raft of decisions under new guidance intended to improve the US patent appeals board process. But it’s a divisive issue, finds Sarah Speight.   24 June 2025

Americas

Regeneron hits Amgen over its blockbuster eye disease treatment

The biotech firm strikes again over Eylea after Amgen launches biosimilar | Regeneron claims Amgen infringed agreed ‘patent dance’ | Follows other lawsuits aimed at protecting Eylea.   19 June 2025

Europe

UPC confirms permanent injunction against Curio in 10x tech dispute

Court affirms infringement of patent covering gene expression technology | Curio Bioscience cannot sell related products in three EU countries | Decision is “further testament to 10x Genomic’s strategic use of IP”, 10x counsel tells LSIPR.   17 June 2025

Europe

UPC promises CMS overhaul with new phased release

Unified Patent Court announces new case management system this summer | Release will be in two phases, with first phase focusing on opt-out functionalities and representatives’ registration.   12 June 2025

Americas

Fed Circ affirms rulings in Acadia’s fight against Parkinson’s drug copies

US appeals court confirms validity of Acadia's Nuplazid patents | Decision fends off generics from MSN Laboratories and Aurobindo Pharma until 2030s.   10 June 2025

Americas

Fed Circ upholds Moderna’s COVID-19 vaccine win against Alnylam

Biotech company convinces judges over claim construction interpretation | Alnylam “acted as lexicographer” regarding a claim term | Win comes as Moderna suffers economic challenges.   5 June 2025

Europe

NanoString to pay 10x Genomics $68m in global settlement

Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on sales of its spatial biology products.   15 May 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.